Division of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester Medical Center, 601 Elmwood Avenue, Box 704, Rochester, NY, 14642, USA.
Center for Biostatistics, The Ohio State University, Columbus, OH, USA.
J Cancer Surviv. 2023 Jun;17(3):769-780. doi: 10.1007/s11764-022-01249-1. Epub 2022 Aug 18.
Older survivors of leukemia and lymphoma often experience long-term effects of chemotherapy. We described common concerns related to their cancer and treatment in older survivors of leukemia and non-Hodgkin lymphoma (NHL) and assessed correlates of these concerns.
We utilized data from the Women's Health Initiative (WHI) Life and Longevity After Cancer (LILAC) study that recruited post-menopausal women aged 50-79. Participants diagnosed with leukemia and NHL were included (n = 420). They were asked about 14 areas of current concerns related to their cancer and treatment and to rate each from 0 (no concern) to 2 (major concern), with total scores ranging from 0 to 28. Linear regression was used to assess factors correlated with the concern score, and logistic regression for factors correlated with the three most common concerns.
Mean age at assessment was 81 years (range 69-99); 72% reported at least one concern, and median concern score among these survivors was 3.5 (Q1-Q3 2-5). Factors significantly correlated with concern scores were sadness, pain, distress, higher prior symptom count, and loneliness (all p < 0.05). Significant factors correlated with common concerns were (1) fatigue/sleep: sadness/depression, distress, higher prior symptom count, greater loneliness, and worse physical functioning; (2) physical functioning/activity: older age, public insurance, higher body mass index, pain, worse QoL, and higher treatment-related comorbidities; (3) memory/concentration: prior chemotherapy or radiation, worse QoL, higher prior symptom count, and greater loneliness (all p < 0.05).
Almost three-quarters of older survivors of leukemia and lymphoma reported at least one concern; a multifaceted intervention may be needed to address these concerns.
白血病和淋巴瘤的老年幸存者通常会经历化疗的长期影响。我们描述了白血病和非霍奇金淋巴瘤(NHL)老年幸存者中与癌症和治疗相关的常见问题,并评估了这些问题的相关性。
我们利用妇女健康倡议(WHI)癌症后生命和长寿(LILAC)研究的数据,该研究招募了 50-79 岁的绝经后妇女。包括患有白血病和 NHL 的参与者(n=420)。他们被问及与癌症和治疗相关的 14 个当前关注领域,并从 0(无关注)到 2(主要关注)对每个领域进行评分,总分为 0 到 28。线性回归用于评估与关注评分相关的因素,逻辑回归用于评估与三个最常见关注相关的因素。
评估时的平均年龄为 81 岁(范围 69-99);72%的人报告了至少一个关注问题,这些幸存者的关注评分中位数为 3.5(四分位距 2-5)。与关注评分显著相关的因素是悲伤、疼痛、痛苦、更高的先前症状数和孤独感(均 P<0.05)。与常见关注相关的显著因素是:(1)疲劳/睡眠:悲伤/抑郁、痛苦、更高的先前症状数、更大的孤独感和更差的身体功能;(2)身体功能/活动:年龄较大、公共保险、更高的体重指数、疼痛、更差的生活质量和更高的与治疗相关的合并症;(3)记忆/注意力:先前的化疗或放疗、更差的生活质量、更高的先前症状数和更大的孤独感(均 P<0.05)。
近四分之三的白血病和淋巴瘤老年幸存者报告了至少一个关注问题;可能需要一种多方面的干预措施来解决这些问题。